Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
TTNP has some late news as Braeburn hired MSL group.... Very large global company Link
http://www.prweekus.com/msl-picked-to-support-opioid-dependence-treatment/article/276555/
Just look at HOW TTNP has traded the last week 4 to 6X's avg Volume & besides block buying look at the crazy support ??? Every time they bid whack it support steps in with 10 to 30K in buying the last week & you think that's pure retail ??? I think not been doing this far to long not to recognize the elephants foot steps.... probably small funds & not huge buying but certainly Institutional sponsorship non the less.... Especially knowing that TTNP will be re listed on Nasdaq later this year..Lastly very odd that the next day after Institutional meetings were held Volume & price both shift into overdrive hmmm odd coincidence... But hey any way great for us longs right GLTY & make $$$$$$$$$
That was certainly not my post or opinion, and have stated seeing TTNP mid $2's to $3 before April approval & $4+ on approval news all just my opinion.... GLTY & make $$$$$$$$$
Your certainly entitled to your opinion but rest assured the blocks gone off the last week which BTW coincided with TTNP having Institutional meetings last Monday7 Tuesday are clearly not retail buyers .... I'm also sure the Nasdaq listing came up during the Institutional meetings as well.... GLTY & make $$$$$$$$$$$
It's obvious TTNP has had Institutional accumulation the last week & typically they buy for weeks not days. They know as well as seasoned biotech investors that TTNP has an unusually high chance of FDA approval in April being that Priority review alone gives them a 75% chance then add it's a 505B application meaning the drug is already been approved on the market for 10 years & proven safe & effective = over 90% chance imo.... Lets also add that the Govt granted 7.6 million dollars to TTNP to help get Probuphine studies complete as the FDA needs & wants too have more options combating an admitted opioid epidemic... Last but not least ask yourself what an FDA approved drug with peak sales of 300 to 500 million a year would typically be valued at ???? 400 mill $$$ 600 ??? 1 Billion ??? Certainly not 140 Million & after backing out cash come May would give TTNP a 60 Million Dollar Market Cap as they will have over 80 million in CASH ....Any way you slice it TTNP is going much higher in the days & weeks ahead and the Big Money knows it & accumulating every day....GLTA & make $$$$$$$$$$$$$$$$$
It's obvious TTNP has had Institutional accumulation the last week & typically they buy for weeks not days. They know as well as seasoned biotech investors that TTNP has an unusually high chance of FDA approval in April being that Priority review alone gives them a 75% chance then add it's a 505B application meaning the drug is already been approved on the market for 10 years & proven safe & effective = over 90% chance imo.... Lets also add that the Govt granted 7.6 million dollars to TTNP to help get Probuphine studies complete as the FDA needs & wants too have more options combating an admitted opioid epidemic... Last but not least ask yourself what an FDA approved drug with peak sales of 300 to 500 million a year would typically be valued at ???? 400 mill $$$ 600 ??? 1 Billion ??? Certainly not 140 Million & after backing out cash come May would give TTNP a 60 Million Dollar Market Cap as they will have over 80 million in CASH ....Any way you slice it TTNP is going much higher in the days & weeks ahead and the Big Money knows it & accumulating every day....GLTA & make $$$$$$$$$$$$$$$$$
TTNP Shylo I have no doubt that Institutional meetings went very well last Mon & Tues as watching trading it's very clear the bigger fish are starting to accumulate TTNP shares .... FDA guidelines help both opioid addiction & will help when Chronic pain indication goes before FDA in the future.... Any way you slice & dice it TTNP will be mid $2's in the days & weeks ahead & much higher upon approval in April....
TTNP current valuation is extremely cheap especially if peak sales of their drug hits Analysts Est of 300 to 500 million dollars also adding in upon approval TTNP will have over 80 million dollars in Cash...Currently 125 Million dollar market cap ??? $2's look like a lock real soon imo...
Jan 7th Investor Presentation Note Nasdaq Up listing for early 2013
http://secfilings.nasdaq.com/filingFrameset.asp?FileName=0001193125%2D13%2D004375%2Etxt&FilePath=%5C2013%5C01%5C07%5C&CoName=TITAN+PHARMACEUTICALS+INC&FormType=8%2DK&RcvdDate=1%2F7%2F2013&pdf=
Analyst Jason Napodano, CFA
http://bionapcfa.blogspot.com/search/label/Titan%20Pharma
priority review press release
http://finance.yahoo.com/news/probuphine-r-receives-fda-priority-120000404.html
Titan's partner deal press release note the 75 Million dollars pledged by partner for commercial roll out of Probuphine.
http://finance.yahoo.com/news/titan-pharmaceuticals-licenses-exclusive-probuphine-120000246.html
Pre partner analyst article naming TTNP & reasons for buying with $4.00 target.
http://seekingalpha.com/article/1064451-do-you-have-the-guts-to-take-on-cutting-edge-biotech-like-this-vc?source=yahoo
A Wall street journal article on opioid addiction & Titans treatment option
http://online.wsj.com/article/SB10001424052702303684004577506983158087406.html?KEYWORDS=titan#articleTabs%3Darticle
TTNP current valuation is extremely cheap especially if peak sales of their drug hits Analysts Est of 300 to 500 million dollars also adding in upon approval TTNP will have over 80 million dollars in Cash...Currently 125 Million dollar market cap ??? $2's look like a lock real soon imo...
Jan 7th Investor Presentation Note Nasdaq Up listing for early 2013
http://secfilings.nasdaq.com/filingFrameset.asp?FileName=0001193125%2D13%2D004375%2Etxt&FilePath=%5C2013%5C01%5C07%5C&CoName=TITAN+PHARMACEUTICALS+INC&FormType=8%2DK&RcvdDate=1%2F7%2F2013&pdf=
Analyst Jason Napodano, CFA
http://bionapcfa.blogspot.com/search/label/Titan%20Pharma
priority review press release
http://finance.yahoo.com/news/probuphine-r-receives-fda-priority-120000404.html
Titan's partner deal press release note the 75 Million dollars pledged by partner for commercial roll out of Probuphine.
http://finance.yahoo.com/news/titan-pharmaceuticals-licenses-exclusive-probuphine-120000246.html
Pre partner analyst article naming TTNP & reasons for buying with $4.00 target.
http://seekingalpha.com/article/1064451-do-you-have-the-guts-to-take-on-cutting-edge-biotech-like-this-vc?source=yahoo
A Wall street journal article on opioid addiction & Titans treatment option
http://online.wsj.com/article/SB10001424052702303684004577506983158087406.html?KEYWORDS=titan#articleTabs%3Darticle
TTNP agreed solid support all day & last few days perfect consolidation days after huge move... just setting up perfectly for next leg up $2's coming soon imo GLTA & make $$$$$$$$$$$$
This framework really sets up TTNP's Chronic pain indication in a very favorable high approval light.... Chronic pain will be twice the sales market opioid addiction sales will be a huge market....As far as Probuphine imo as close to 100% approval chance as a bio can get....
TZYM nice trade booked um .62 from .54's
TTNP really great news for Chronic pain indication that TTNP will have on board next
TTNP certainly clear the heat on FDA regarding Opiates & over prescribing for years & now we have a huge new amount of opioid addicts whether the masses realize it or not but rest assured FDA will easily grant FDA approval for anything that helps combat opioid addiction. Imo only TTNP is as close to a 100% approval as they come.... Also lets not forget TTNP can still partner for the rest of the globe outside U.S & Canada for opioid addiction & Chronic pain indication will be an even larger market then opioid's GLTA & make $$$$$$$$$
TZYM agreed didn't act well tomorrow s/b telling.... If vol rocks in A.M. could & should take a run held into tomorrow... GLTA & make $$$$$$$$$$$
TZYM in some here on milestone potential from Bristol-Myers news link Vol well above avg & trading far below cash on hand
http://finance.yahoo.com/news/tranzyme-pharma-announces-successful-completion-101000250.html
TTNP triggered a big buy signal yesterday new 52 week Hi's on Vol plus it is clear that the institutional meetings the last 2 days went well. Institutions don't buy what they want in 1 or 2 days they tend to buy for weeks. Imo we will continue to walk up into mid $2's over the next few days & weeks...
TTNP triggered a big buy signal yesterday new 52 week Hi's on Vol plus it is clear that the institutional meetings the last 2 days went well. Institutions don't buy what they want in 1 or 2 days they tend to buy for weeks. Imo we will continue to walk up into mid $2's over the next few days & weeks...
TTNP 8K out Investor meetings today & presentation link also notes Nasdaq up listing in 2013.
http://secfilings.nasdaq.com/filingFrameset.asp?FileName=0001193125%2D13%2D004375%2Etxt&FilePath=%5C2013%5C01%5C07%5C&CoName=TITAN+PHARMACEUTICALS+INC&FormType=8%2DK&RcvdDate=1%2F7%2F2013&pdf=
TTNP spoke with CEO today will be up listing later this year onto Nasdaq & has multiple institutional meetings next week with JPM healthcare conference in San Francisco... Imo will steadily walk over $2.00 over the next few weeks into April PDUFA.
TTNP DD post $1.38 pps 103 Million dollar market cap. has currently 22 million in cash with approx 64 million due to TTNP upon FDA approval & warrant conversions = 86 million dollars less cash burn through April which is very low right now. TTNP has been around for 20 years & started out as a listed company but share price fell well below listing standards & went to the BB always with completed filings & CEO stated 2013 up listing a priority. Titan has a unique delivery system implantable drug delivery with a continuous 6 month dosage in 1 match stick sized implant in the upper arm. Think about the compliance improvement for not just opioid addiction but chronic pain, Parkinson's, Alzheimer's etc all drugs where compliance is absolutely necessary but typically does not happen. I will post some good articles & Analyst information too start with.
Analyst Jason Napodano, CFA
http://bionapcfa.blogspot.com/search/label/Titan%20Pharma
priority review press release
http://finance.yahoo.com/news/probuphine-r-receives-fda-priority-120000404.html
Titan's partner deal press release note the 75 Million dollars pledged by partner for commercial roll out of Probuphine.
http://finance.yahoo.com/news/titan-pharmaceuticals-licenses-exclusive-probuphine-120000246.html
Pre partner analyst article naming TTNP & reasons for buying with $4.00 target.
http://seekingalpha.com/article/1064451-do-you-have-the-guts-to-take-on-cutting-edge-biotech-like-this-vc?source=yahoo
A Wall street journal article on opioid addiction & Titans treatment option
http://online.wsj.com/article/SB10001424052702303684004577506983158087406.html?KEYWORDS=titan#articleTabs%3Darticle
TTNP DD post $1.38 pps 103 Million dollar market cap. has currently 22 million in cash with approx 64 million due to TTNP upon FDA approval & warrant conversions = 86 million dollars less cash burn through April which is very low right now. TTNP has been around for 20 years & started out as a listed company but share price fell well below listing standards & went to the BB always with completed filings. Titan has a unique delivery system implantable drug delivery with a continuous 6 month dosage in 1 match stick sized implant in the upper arm. Think about the compliance improvement for not just opioid addiction but chronic pain, Parkinson's, Alzheimer's etc all drugs where compliance is absolutely necessary but typically does not happen. I will post some good articles & Analyst information too start with.
Analyst Jason Napodano, CFA
http://bionapcfa.blogspot.com/search/label/Titan%20Pharma
priority review press release
http://finance.yahoo.com/news/probuphine-r-receives-fda-priority-120000404.html
Titan's partner deal press release note the 75 Million dollars pledged by partner for commercial roll out of Probuphine.
http://finance.yahoo.com/news/titan-pharmaceuticals-licenses-exclusive-probuphine-120000246.html
Pre partner analyst article naming TTNP & reasons for buying with $4.00 target.
http://seekingalpha.com/article/1064451-do-you-have-the-guts-to-take-on-cutting-edge-biotech-like-this-vc?source=yahoo
A Wall street journal article on opioid addiction & Titans treatment option
http://online.wsj.com/article/SB10001424052702303684004577506983158087406.html?KEYWORDS=titan#articleTabs%3Darticle
TTNP some DD 100 mill $$$ Mkt Cap & as per partner CC ended year with approx 22 million in cash plus now that priority review granted upon approval gets another 50 Million Dollars plus some $1.25 warrants will be exercised in 2013 adding another 14 million in cash. So no dilution worries anymore. Also with Priority review the approval rate doubles to 75% chance of approval versus 38% on Standard review
http://www.fda.gov/downloads/Drugs/DevelopmentApprovalProcess/DrugInnovation/UCM293684.pdf
2012 Priority review approvals = 77%
Just got great terms & numbers on partner deal
http://finance.yahoo.com/news/titan-pharmaceuticals-licenses-exclusive-probuphine-120000246.html
Also keep in mind buprenorphine hydrochloride has been approved & used for last 10 years in pill form & now sub-lingual but compliance is still very low. TTNP with an implantable 6 month dosage will have triple digit improvement in compliance & should easily become the gold standard in opioid treatment. TTNP will be entering a double digit yearly growth drug arena currently doing over 1.3 Billion a year in sales & fairly conservative & safe to say TTNP should garner 300 to 500 million in peak sales.All for 100 Million dollar market cap ??? will have 85 million in cash upon approval.
TKMR $5.07 waking up trading for cash RNA interface delivery with bright future
http://finance.yahoo.com/news/tiny-tekmira-lands-65m-settlement-124603532.html
TKMR added a few $4.75 trading well below cash & RNA co like SRPT etc.... Getting pipeline & numerous partner deals for free. Also with patent validation should garner more partner deals soon.
TKMR is a Nasdaq stock has 13.5 mill shares outstanding. Foreign filer from Canada so no 10Q's only 20F annual. Same RNA field as SRPT that went from $3 to $45 this year & gotta believe TKMR worth a whole lot more then $4.90 which is less then cash in the bank.
TKMR not sure how Bio guys look at RNAi but seems TKMR has nice patents & lead in field
http://seekingalpha.com/article/1010711-tekmira-could-offer-stockholders-huge-rewards?source=yahoo
Tekmira Pharmaceuticals Corporation is a biopharmaceutical company focused on advancing novel RNA interference therapeutics (RNAi therapeutics) and providing its leading lipid nanoparticle delivery technology to pharmaceutical partners. Tekmira has been working in the field of nucleic acid delivery for over a decade and has broad intellectual property covering LNPs.
RNAi therapeutics have the potential to treat a broad number of human diseases by "silencing" disease causing genes. The discoverers of RNAi, Stanford University's Andrew Z. Fire and University of Massachusetts' Craig C. Mello, were awarded the 2006 Nobel Prize for Physiology or Medicine "for their discovery of RNA interference - gene silencing by double-stranded RNA," a gene silencing mechanism used by all cells.
RNAi therapeutics, such as "siRNAs," require delivery technology to be effective systemically. Tekmira's LNP technology is probably the most widely adopted delivery technology for the systemic delivery of RNAi therapeutics. Tekmira's LNP formulations are manufactured by a proprietary method and LNP-based products have been reviewed by multiple FDA divisions for use in clinical trials. LNP formulations comprise several lipid components that can be adjusted to suit the specific application. Tekmira may be small, but this company has a big lead in RNAi therapeutics that could translate into significant rewards to shareholders who invest at this stage of their promising development.
TKMR getting way cheap 67 Mill $$ market cap & ALNY settlement giving TKMR 75 mill $$$ plus the 5 mill they had & values pipeline at zero & multiple partner deals also.
TKMR back below Cash in bank value. Pipeline & partner deals valued at zero & last time retraced back to $5 jumped to $5.60's within days
with several near term catalysts TTNP s/b a nice % winner the next month GLTA & make $$$$$$
TKMR back in off 75 Mill $$$ award from ALNY $5.30 was $7.00+ on settlement news. Trading below cash & values entire pipeline at zero. Plus has over 1/2 dozen drugs with partners utilizing TKMR's delivery platform for milestones & royalties plus Govt Ebola $$$$ & recent partner FDA approval for new drug.
TKMR gets 75 Million from ALNY in settlement & validates all patents & rights to MC2 & ALNY's MC3 now all TKMR's very big win for a small Bio only 14 million shares outstanding s/b a big day for TKMR.
http://www.nasdaq.com/article/tekmira-and-alnylam-restructure-relationship-and-settle-all-litigation-20121112-01318#.UKGppYY8B8E
TKMR another article about trial with ALNY this week.
http://www.chimeraresearchgroup.com/?p=9263
TKMR near 52 week highs Trial with ANLY starts this week s/b a mover nice intial read to catch up on under the radar play
http://finance.yahoo.com/news/break-tekmira-ahead-next-weeks-121102289.html
WPRT Nat Gas play beaten up lately s/b winner on Romney win CLNE already running
LF reported beat & raise yet getting clobbered bounce play ?
FONR been in a base @ $5 for a while after great earnings run inching up maybe ready for push higher... reports next week
HZNP here we go $2.50's & deeply oversold
RDN big mover recently down double digit % trying to recover
Sorry guys new to this board thanks for heads up GLTA & make $$$$$$$$